NDA-applicants often launch products with no or limited composition of matter patent (drug substance) protection. When science permits, solid forms, such as polymorphs, salts, cocrystals, and solid dispersions present tremendous opportunity for obtaining drug substance Orange Book listable patent protection for valuable pharmaceutical products. Eyal Barash has been working in solid-state chemistry and with solid form patents for over 20 years and advises clients and prepares and prosecutes patent applications directed to these high-value assets.

Many Barash Law clients are start-ups who have in-licensed technology from academic institutions or other entities.  Licenses can range from patent licenses where deal value is predicated on the ability to stop competition to technology licenses where trade secrets are the critical IP asset.  Barash Law counsels clients to ensure the licensing and business needs align and the intellectual property license fits within the business plan and market realities.

A comprehensive intellectual property development strategy is complex for any company, but especially challenging for early-stage research-based companies.  Barash Law takes a deep dive into its clients' intellectual property and business needs to stratify intellectual property values and pursue goals in a timely and cost effective way.  Barash Law can help emerging companies to succeed by reducing risk while creating marketplace interest in their product.

Barash Law has been performing in-house counsel duties for its clients since its formation in 2009.  These functions include negotiating standard business agreements such as non-disclosure agreements, service agreements, terms and conditions, licenses, and similar agreements. Where legal functions are outside Barash Law's areas of expertise, Barash Law has a network of on call specialists with whom we regularly collaborate.